Here are three updates on GI companies to note from the past week.
Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa made a bet on his salary as half of his compensation package relies on Valeant's stock performance.
Valeant Pharmaceuticals' former CEO Michael Pearson is suing the company for 3 million in shares that the company allegedly withheld from his exit package.
Irving, Texas-based Miraca Life Sciences expanded its InformTx therapeutic drug monitoring program to include Simponi and patient-developed antibodies to Simponi.